GlaxoSmithKline PLC (NYSE:GSK)

44.54
BATS BZX Real-Time Price
As of 10:43am ET
 -0.25 / -0.56%
Today’s Change
41.25
Today|||52-Week Range
54.78
+4.21%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$109.0B

Company Description

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare business markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.

Contact Information

GlaxoSmithKline Plc
980 Great West Road
Brentford Greater London TW8 9GS
P:442080475000
Investor Relations:

Employees

Shareholders

Other institutional7.16%
Mutual fund holders3.26%
Individual stakeholders--

Top Executives

Andrew Philip WittyChief Executive Officer & Executive Director
Simon DingemansChief Financial Officer & Executive Director
Nick HironsSenior VP-Global Ethics & Compliance Officer
Zhi HongSenior Vice President
Daniel E. TroySenior Vice President & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account